Prevalence of serum IgG antibodies against SARS-CoV-2 among clinic staff

被引:45
|
作者
Schmidt, Simone B. [1 ]
Grueter, Ludwig [2 ]
Boltzmann, Melanie [1 ]
Rollnik, Jens D. [1 ]
机构
[1] Hannover Med Sch, Associated Inst, Inst Neurorehabil Res, BDH Clin Hessisch Oldendorf, Hessisch Oldendorf, Germany
[2] Nordlab, Hameln, Germany
来源
PLOS ONE | 2020年 / 15卷 / 06期
关键词
D O I
10.1371/journal.pone.0235417
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The SARS-CoV-2 pandemic threatens health care providers and society. For planning of treatment capacities, it is of major importance to obtain reliable information on infection and fatality rates of the novel coronavirus. A German community study, the so-called Heinsberg study, found a 5-fold higher infection rate (and thus a remarkably lower fatality rate) than the officially reported cases suggest. We were interested to examine the SARS-CoV-2-IgG antibody status among clinic staff of a large neurological center in Northern Germany. Blood samples and questionnaires (demographic data, medical history) were collected pseudonymously. In total, 406 out of 525 (77.3%) of our employees participated in the study. The infection rate among the staff was as high as 2.7%. Including drop-outs (missing questionnaire but test result available), the infection rate was even higher (2.9%). Only 36% of the positively tested employees did suffer from flu-like symptoms in 2020. None of the nurses-having closest and longest contact to patients-were found to be positive. Despite the fact that the infection rate among clinic staff may not be directly compared to the situation in the surrounding county (due to different testing procedures), one might hypothesize that the infection rate could be more than 30-fold higher than the number of officially reported cases for the county of Hameln-Pyrmont. The high rate of IgG-positive, asymptomatic healthcare workers might help to overcome fears in daily work.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Prevalence of IgG antibodies induced by the SARS-COV-2 virus in asymptomatic adults in Nuevo Leon, Mexico
    Rodriguez-Vidales, Edgar P.
    Garza-Carrillo, Denise
    Perez-Trujillo, Jose J.
    Robles-Rodriguez, Olivia A.
    Salinas-Martinez, Ana Maria
    De Oca-Luna, Roberto Montes
    Trevino-Garza, Consuelo
    De La O-Cavazos, Manuel E.
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (10) : 5873 - 5879
  • [42] SARS-CoV-2 antibodies in ICU and clinic staff From Germany's region with the highest infection rate
    Finkenzeller, T.
    Faltlhauser, A.
    Dietl, K-H
    Paetzel, C.
    Szczypien, N.
    Klawonn, F.
    Bodmann, K-F
    von Meyer, A.
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2020, 115 (SUPPL 3) : 139 - 145
  • [43] Effect of Protective Measures on the Risk of SARS-CoV-2 Infection among Eye Clinic Staff Members
    Sanak, Frantisek
    Faes, Livia
    Eppenberger, Leila
    Baenninger, Philipp
    Kaufmann, Claude
    Golla, Kathrin
    Bachmann, Lucas
    Buhl, Daniela
    Schmid, Martin K.
    Thiel, Michael
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2022, 239 (04) : 605 - 609
  • [44] Detection of SARS-CoV-2 IgG antibodies in dried blood spots
    Turgeon, Coleman T.
    Sanders, Karen A.
    Granger, Dane
    Nett, Stephanie L.
    Hilgart, Heather
    Matern, Dietrich
    Theel, Elitza S.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 101 (01)
  • [45] Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon
    Omar Bahlawan
    Rebecca Badra
    Hanna Semaan
    Nancy Fayad
    Mina Nabil Kamel
    Ahmed N. El Taweel
    Mokhtar R. Gomaa
    Abeer Sirawan
    Atika Berry
    Jacques Mokhbat
    Jimi Goldstein
    Jad Abdallah
    Ghazi Kayali
    Archives of Virology, 2022, 167 : 1509 - 1519
  • [46] Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon
    Bahlawan, Omar
    Badra, Rebecca
    Semaan, Hanna
    Fayad, Nancy
    Kamel, Mina Nabil
    El Taweel, Ahmed N.
    Gomaa, Mokhtar R.
    Sirawan, Abeer
    Berry, Atika
    Mokhbat, Jacques
    Goldstein, Jimi
    Abdallah, Jad
    Kayali, Ghazi
    ARCHIVES OF VIROLOGY, 2022, 167 (07) : 1509 - 1519
  • [47] Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers
    Morris, Claudia R.
    Sullivan, Patrick
    Mantus, Grace
    Sanchez, Travis
    Zlotorzynska, Maria
    Hanberry, Bradley
    Iyer, Srikant
    Heilman, Stacy
    Camacho-Gonzalez, Andres
    Figueroa, Janet
    Manoranjithan, Shaminy
    Leake, Deborah
    Mendis, Reshika
    Cleeton, Rebecca
    Chen, Christie
    Krieger, Rachel
    Bush, Patricia
    Hughes, Tiffany
    Little, Wendalyn K.
    Suthar, Mehul S.
    Wrammert, Jens
    Vos, Miriam B.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 474 - 481
  • [48] SARS-CoV-2: Prevalence among Hospital Employees
    Manych, Matthias
    PNEUMOLOGIE, 2021, 75 (02): : 87 - 87
  • [49] Prevalence of antibodies and SARS-CoV-2 vaccination in Mexico 2022
    Carnalla, Martha
    Basto-Abreu, Ana
    Stern, Dalia
    Arantxa Colchero, M.
    Bautista-Arredondo, Sergio
    Alpuche-Aranda, Celia M.
    Martinez-Barnetche, Jesus
    Romero-Martinez, Martin
    Cortes-Alcala, Ricardo
    Lopez-Martinez, Irma
    Aparicio-Antonio, Rodrigo
    Barrientos-Gutierrez, Tonatiuh
    SALUD PUBLICA DE MEXICO, 2023, 65 : S135 - S145
  • [50] Liver or Kidney Transplantation After SARS-CoV-2 Infection: Prevalence, Short-term Outcome, and Kinetics of Serum IgG Antibodies
    Verbeek, Jef
    Vrij, Casper
    Vermeersch, Pieter
    Van Elslande, Jan
    Vets, Sofie
    Lagrou, Katrien
    Vos, Robin
    van Cleemput, Johan
    Jochmans, Ina
    Monbaliu, Diethard
    Pirenne, Jacques
    Kuypers, Dirk
    Nevens, Frederik
    TRANSPLANTATION, 2022, 106 (04) : 862 - 868